Work

Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.

Year: 2001

Type: article

Source: The American Journal of Cardiology

DOI: 10.1016/s0002-9149(01)01454-0

Authors: Fergus McTaggart, Linda Buckett, Robert Davidson, Geoffry Holdgate, Alex McCormick, Dennis Schneck, Graham Smith, Michael Warwick

Institutions: AstraZeneca (United Kingdom), AstraZeneca (United States)

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2033511358

FWCI: 19.36

Cites: 6

Cited by: 413

Related to: 10